Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07825753 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer

Study acronym: PROBE
StatusNot Yet Recruiting
PhasePhase 2
Started2026-09-10
View on ClinicalTrials.gov ↗
624 trials monitored
See 9 trials at risk
5,180 trials monitored
See 256 trials at risk
1,634 trials monitored
See 90 trials at risk
To evaluate the clinical efficacy (objective response rate, ORR) of mass spectrometry-based absolute quantification-guided selection and matching of ADC/PDC therapy in patients with locally advanced or metastatic pancreatic cancer/breast cancer, and to explore a quantitative threshold-based stratification strategy for identifying a "hidden benefit population
Trial Details
NCT Number NCT07825753
Lead Sponsor Fudan University
Conditions Advanced or Metastatic Pancreatic Adenocarcinoma, Advanced or Metastatic Breast Cancer (BC)
Enrollment 225 participants
Start Date 2026-09-10
Primary Completion 2027-09-01 (estimated)
Study Completion 2030-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-17